Immune Activation Could Hold the Key to Success of Dual-Target CAR T Therapy in Glioblastoma
Recurrent glioblastoma (GBM), a notoriously aggressive and lethal brain cancer, continues to pose a formidable challenge for oncology, partly due ...
Recurrent glioblastoma (GBM), a notoriously aggressive and lethal brain cancer, continues to pose a formidable challenge for oncology, partly due ...
In a groundbreaking cohort study recently published in JAMA Internal Medicine, researchers have uncovered compelling evidence that the 2024-2025 COVID-19 ...
In a groundbreaking revelation that intertwines mental health with the longevity of independent living, researchers from Tohoku University, alongside collaborators ...
In the realm of cellular biology, the equilibrium between chromatin packaging and nuclear division stands as a cornerstone for genomic ...
In recent years, the integration of generative artificial intelligence (AI) into various facets of life has accelerated dramatically, with college ...
In a groundbreaking phase 3 international clinical trial, researchers have unveiled a promising new immunotherapy combination that could redefine the ...
Alzheimer’s disease stands as the predominant cause of dementia affecting over seven million individuals in the United States alone. A ...
A landmark study published in Nature Health has unveiled unprecedented insights into medication use across England, charting detailed patterns from ...
University of Melbourne researchers have unveiled troubling insights into the welfare of greyhounds in the United Kingdom’s greyhound racing industry, ...
Australian universities have long been esteemed for their contributions to public health research, yet recent investigations by a team at ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine